WS #17011
In the earnings stream, Vistra Energy reported a 50% year-over-year surge in Q3 EBITDA, driven by interest and rental income, and raised its full-year guidance, causing its stock to climb 5%. Similarly, Moderna flipped to profitability with EPS of $0.38 versus expectations of a loss, and raised its 2026 growth guide to 15-25%. These results highlight a bifurcation in the market where cash-generative utilities and biotech firms with clear catalysts are attracting capital, while legacy telecoms like Charter continue to struggle with structural subscriber declines.
Corporate Earnings: Utilities and Biotech Resilience
In the earnings stream, Vistra Energy reported a 50% year-over-year surge in Q3 EBITDA, driven by interest and rental income, and raised its full-year guidance, causing its stock to climb 5%. Similarly, Moderna flipped to profitability with EPS of $0.38 versus expectations of a loss, and raised its 2026 growth guide to 15-25%. These results highlight a bifurcation in the market where cash-generative utilities and biotech firms with clear catalysts are attracting capital, while legacy telecoms like Charter continue to struggle with structural subscriber declines.